COMMUNITY HEALTHCARE TRUST I (CHCT) Fundamental Analysis & Valuation

NYSE:CHCTUS20369C1062

Current stock price

17.58 USD
+0.2 (+1.15%)
At close:
17.58 USD
0 (0%)
After Hours:

This CHCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CHCT Profitability Analysis

1.1 Basic Checks

  • In the past year CHCT was profitable.
  • In the past year CHCT had a positive cash flow from operations.
  • Of the past 5 years CHCT 4 years were profitable.
  • In the past 5 years CHCT always reported a positive cash flow from operatings.
CHCT Yearly Net Income VS EBIT VS OCF VS FCFCHCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.21%, CHCT is in line with its industry, outperforming 43.80% of the companies in the same industry.
  • CHCT's Return On Equity of 0.48% is in line compared to the rest of the industry. CHCT outperforms 43.80% of its industry peers.
  • CHCT has a Return On Invested Capital of 2.35%. This is comparable to the rest of the industry: CHCT outperforms 42.98% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHCT is in line with the industry average of 3.11%.
  • The last Return On Invested Capital (2.35%) for CHCT is above the 3 year average (2.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.21%
ROE 0.48%
ROIC 2.35%
ROA(3y)0.05%
ROA(5y)1%
ROE(3y)0.07%
ROE(5y)1.69%
ROIC(3y)2.34%
ROIC(5y)2.72%
CHCT Yearly ROA, ROE, ROICCHCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3 4

1.3 Margins

  • CHCT has a Profit Margin (1.72%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of CHCT has declined.
  • CHCT has a Operating Margin (23.88%) which is in line with its industry peers.
  • CHCT's Operating Margin has declined in the last couple of years.
  • CHCT has a Gross Margin of 80.51%. This is amongst the best in the industry. CHCT outperforms 80.99% of its industry peers.
  • CHCT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.88%
PM (TTM) 1.72%
GM 80.51%
OM growth 3Y-11.69%
OM growth 5Y-8.33%
PM growth 3Y-55.61%
PM growth 5Y-40.38%
GM growth 3Y-1%
GM growth 5Y-0.37%
CHCT Yearly Profit, Operating, Gross MarginsCHCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1

2. CHCT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHCT is destroying value.
  • Compared to 1 year ago, CHCT has more shares outstanding
  • The number of shares outstanding for CHCT has been increased compared to 5 years ago.
  • Compared to 1 year ago, CHCT has a worse debt to assets ratio.
CHCT Yearly Shares OutstandingCHCT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
CHCT Yearly Total Debt VS Total AssetsCHCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.87, we must say that CHCT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CHCT (0.87) is better than 65.29% of its industry peers.
  • CHCT has a Debt/Equity ratio of 1.25. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CHCT (1.25) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.35
WACC6.81%
CHCT Yearly LT Debt VS Equity VS FCFCHCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • CHCT has a Current Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.47, CHCT is not doing good in the industry: 76.86% of the companies in the same industry are doing better.
  • CHCT has a Quick Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CHCT's Quick ratio of 0.18 is on the low side compared to the rest of the industry. CHCT is outperformed by 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.18
CHCT Yearly Current Assets VS Current LiabilitesCHCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

6

3. CHCT Growth Analysis

3.1 Past

  • CHCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.43%, which is quite impressive.
  • CHCT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.76% yearly.
  • Looking at the last year, CHCT shows a very negative growth in Revenue. The Revenue has decreased by -16.49% in the last year.
  • Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 9.88% on average per year.
EPS 1Y (TTM)71.43%
EPS 3Y-24%
EPS 5Y-14.76%
EPS Q2Q%1275%
Revenue 1Y (TTM)-16.49%
Revenue growth 3Y7.45%
Revenue growth 5Y9.88%
Sales Q2Q%5.64%

3.2 Future

  • Based on estimates for the next years, CHCT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.29% on average per year.
  • CHCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.71% yearly.
EPS Next Y33.17%
EPS Next 2Y29.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.37%
Revenue Next 2Y7.48%
Revenue Next 3Y10.05%
Revenue Next 5Y9.71%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CHCT Yearly Revenue VS EstimatesCHCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M
CHCT Yearly EPS VS EstimatesCHCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8

2

4. CHCT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 48.83, CHCT can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as CHCT.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, CHCT is valued quite expensively.
  • With a Price/Forward Earnings ratio of 36.67, CHCT can be considered very expensive at the moment.
  • CHCT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 69.42% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. CHCT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 48.83
Fwd PE 36.67
CHCT Price Earnings VS Forward Price EarningsCHCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • CHCT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.27
CHCT Per share dataCHCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • CHCT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CHCT's earnings are expected to grow with 29.29% in the coming years.
PEG (NY)1.47
PEG (5Y)N/A
EPS Next 2Y29.29%
EPS Next 3YN/A

8

5. CHCT Dividend Analysis

5.1 Amount

  • CHCT has a Yearly Dividend Yield of 11.10%, which is a nice return.
  • Compared to an average industry Dividend Yield of 7.43, CHCT pays a better dividend. On top of this CHCT pays more dividend than 95.87% of the companies listed in the same industry.
  • CHCT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 11.1%

5.2 History

  • The dividend of CHCT has a limited annual growth rate of 2.43%.
  • CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHCT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.43%
Div Incr Years10
Div Non Decr Years10
CHCT Yearly Dividends per shareCHCT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 2580.24% of the earnings are spent on dividend by CHCT. This is not a sustainable payout ratio.
  • The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP2580.24%
EPS Next 2Y29.29%
EPS Next 3YN/A
CHCT Yearly Income VS Free CF VS DividendCHCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M
CHCT Dividend Payout.CHCT Dividend Payout, showing the Payout Ratio.CHCT Dividend Payout.PayoutRetained Earnings

CHCT Fundamentals: All Metrics, Ratios and Statistics

COMMUNITY HEALTHCARE TRUST I

NYSE:CHCT (4/28/2026, 8:19:30 PM)

After market: 17.58 0 (0%)

17.58

+0.2 (+1.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Industry Strength70.19
Industry Growth59.63
Earnings (Last)02-17
Earnings (Next)05-05
Inst Owners79.4%
Inst Owner Change-0.49%
Ins Owners5.82%
Ins Owner Change2.5%
Market Cap502.26M
Revenue(TTM)121.19M
Net Income(TTM)2.08M
Analysts80
Price Target18.87 (7.34%)
Short Float %2.71%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 11.1%
Yearly Dividend1.89
Dividend Growth(5Y)2.43%
DP2580.24%
Div Incr Years10
Div Non Decr Years10
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)163.48%
Min EPS beat(2)-63.24%
Max EPS beat(2)390.2%
EPS beat(4)1
Avg EPS beat(4)45.11%
Min EPS beat(4)-88.54%
Max EPS beat(4)390.2%
EPS beat(8)1
Avg EPS beat(8)-4.32%
EPS beat(12)2
Avg EPS beat(12)-25.93%
EPS beat(16)2
Avg EPS beat(16)-23.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-3.35%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-3.35%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.25%
Revenue beat(12)1
Avg Revenue beat(12)-2.86%
Revenue beat(16)1
Avg Revenue beat(16)-2.66%
PT rev (1m)-1.33%
PT rev (3m)3.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 48.83
Fwd PE 36.67
P/S 4.14
P/FCF N/A
P/OCF 8.9
P/B 1.17
P/tB 1.17
EV/EBITDA 14.27
EPS(TTM)0.36
EY2.05%
EPS(NY)0.48
Fwd EY2.73%
FCF(TTM)-1
FCFYN/A
OCF(TTM)1.98
OCFY11.24%
SpS4.24
BVpS15.03
TBVpS14.98
PEG (NY)1.47
PEG (5Y)N/A
Graham Number11.0335 (-37.24%)
Profitability
Industry RankSector Rank
ROA 0.21%
ROE 0.48%
ROCE 2.98%
ROIC 2.35%
ROICexc 2.36%
ROICexgc 2.39%
OM 23.88%
PM (TTM) 1.72%
GM 80.51%
FCFM N/A
ROA(3y)0.05%
ROA(5y)1%
ROE(3y)0.07%
ROE(5y)1.69%
ROIC(3y)2.34%
ROIC(5y)2.72%
ROICexc(3y)2.35%
ROICexc(5y)2.74%
ROICexgc(3y)2.4%
ROICexgc(5y)2.8%
ROCE(3y)2.96%
ROCE(5y)3.45%
ROICexgc growth 3Y-9.81%
ROICexgc growth 5Y-6.84%
ROICexc growth 3Y-9.27%
ROICexc growth 5Y-6.96%
OM growth 3Y-11.69%
OM growth 5Y-8.33%
PM growth 3Y-55.61%
PM growth 5Y-40.38%
GM growth 3Y-1%
GM growth 5Y-0.37%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA 7.39
Cap/Depr 195.51%
Cap/Sales 70.24%
Interest Coverage 1.12
Cash Conversion 77.86%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.18
Altman-Z 0.87
F-Score5
WACC6.81%
ROIC/WACC0.35
Cap/Depr(3y)239.76%
Cap/Depr(5y)272.78%
Cap/Sales(3y)86.16%
Cap/Sales(5y)94.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.43%
EPS 3Y-24%
EPS 5Y-14.76%
EPS Q2Q%1275%
EPS Next Y33.17%
EPS Next 2Y29.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.49%
Revenue growth 3Y7.45%
Revenue growth 5Y9.88%
Sales Q2Q%5.64%
Revenue Next Year6.37%
Revenue Next 2Y7.48%
Revenue Next 3Y10.05%
Revenue Next 5Y9.71%
EBIT growth 1Y-27.37%
EBIT growth 3Y-5.11%
EBIT growth 5Y0.72%
EBIT Next Year263.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.16%
OCF growth 3Y-2.18%
OCF growth 5Y3.13%

COMMUNITY HEALTHCARE TRUST I / CHCT Fundamental Analysis FAQ

What is the fundamental rating for CHCT stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHCT.


What is the valuation status for CHCT stock?

ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.


How profitable is COMMUNITY HEALTHCARE TRUST I (CHCT) stock?

COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 5 / 10.


What is the earnings growth outlook for COMMUNITY HEALTHCARE TRUST I?

The Earnings per Share (EPS) of COMMUNITY HEALTHCARE TRUST I (CHCT) is expected to grow by 33.17% in the next year.


How sustainable is the dividend of COMMUNITY HEALTHCARE TRUST I (CHCT) stock?

The dividend rating of COMMUNITY HEALTHCARE TRUST I (CHCT) is 8 / 10 and the dividend payout ratio is 2580.24%.